Freedom Leaf Enters $20 Billion Anti-Cholesterol Market With
Acquisition of a Patent Pending Non-Prescription Formula. No FDA
Approval Required. Complimentary Diversification In Health Care
While This Formula is Not Hemp Extract-Based, it Fits Perfectly
with Our Focus on Health & Wellness, Including Our Ayurvedic
Herbal Formulas
Las Vegas, NV -- June 21, 2018 -- InvestorsHub NewsWire
-- Freedom Leaf, Inc. (OTCQB: FRLF), has
acquired the patent pending for a natural cholesterol lowering
formula developed by Healthy Discovery Associates Corp.
Clinical trials for this product indicate significant improvements
in reducing cholesterol levels. This is a dietary supplement
and will not require FDA approval.
Freedom Leaf acquired the patent pending application for
1,400,000 shares of FRLF common stock,
subject to a leak-out agreement.
Clifford J. Perry, Freedom Leaf CEO and co-founder, explains:
“High cholesterol is considered a major factor in cardiovascular
disease, and the market for statins, the leading category of
prescription anti-cholesterol drugs, exceeds $20 billion annually.
Unfortunately, statins are not well tolerated by many patients, who
seek out alternatives in the dietary supplement market. While this
formula is not hemp extract-based, it fits perfectly with our focus
on health and wellness, including our Ayurvedic herbal
formulas, sold under the Hempology brand. We hope to have this
supplement on the market within the next 4 to
6 months.”
The product development scientists of the patent pending formula
are Allan S Kaplan Ph.D. and Harvey Katz, Ph.D. Dr Kaplan’s
degree is in Pharmaceutical Chemistry; and, he has worked as a
Senior Pharmaceutical Executive with companies and their
Subsidiaries, including: Merck, McNeil, Smith Kline and
others. He has been involved in developing pharmaceutical
products and been Director of up to 70 person formulating
teams. He has been published in Pharmaceutical Research
Digest.
Dr. Katz has an extended career in Nutraceutical companies,
Environmental Chemical Company, Renewable Energy and Emergency
Power Systems - all as CEO. He started Healthy Discovery
Associates with Dr. Kaplan and two others. He led the
product development team shepherding it through the clinical
trials.
“Both Dr. Katz and Dr. Kaplan will be available to work with our
in-house formulator to make any necessary changes,” Added
Perry. “With Drs. Katz and Kaplan’s continued help, our goal is to
market the current formula to a broad need-based consumer market
through our growing platform of sales outlets as well as another
formulation with the addition of Full Spectrum Hemp Oil as part a
dietary supplement for prevention against and reduction of
cholesterol.”
Freedom Leaf CFO, Richard Groberg, noted: “This acquisition
represents another exciting addition to the Freedom Leaf family. I
look forward to being able to focus on helping accelerate this and
other recent additions once we complete our 10-Q filing. We
are working closely with our new auditor who is completing their
review procedures. We anticipate filing our Quarterly Report
in the near future.”
About Freedom Leaf, Inc.®
Freedom Leaf, Inc. is a group of diversified,
international, vertically-integrated hemp businesses concentrating
on health, wellness, and education as well as cannabis and hemp
media companies. Freedom Leaf Inc. is a fully-reporting and audited
publicly-traded company under the
symbol (OTCQB: FRLF).
Freedom Leaf Inc. has been a leading go-to resource in the
cannabis, medical marijuana and industrial hemp industries since
2014, founded by professionals with over 200 years combined
experience in marijuana and hemp legalization
advocacy. FRLF is building a diverse
portfolio of valuable businesses through strategic mergers,
acquisitions, and acceleration projects across the industry.
FRLF’s large portfolio of acquisitions and
properties includes: our full spectrum hemp
oil product line and formulation facility - Irie
CBD in Oakland, CA ; our wholly-owned hemp
extraction facility in N. Las Vegas, NV, Leafceuticals,
Inc.; our exclusive health and wellness full spectrum hemp oil
brand - Hempology, our just-acquired indoor 430,000
square foot greenhouse nursery in Valencia, Spain for the
cultivation of Hemp; our hemp-based rolling paper
company - Plants to Paper; two of the largest
Spanish-speaking cannabis web portals in the
world - LaMarihuana.com and Marihuana-Medicinal.com,
and of course our flagship publication - Freedom Leaf
Magazine.
Utilizing these mergers and acquisitions, Freedom Leaf Inc. is
continually building a solid foundation for our
vertically-integrated hemp company to maximize both revenue growth,
and net profit, which will increase our shareholders value. Our
cultivation and extraction divisions
allow FRLF to grow and source our own
full spectrum hemp CBD, which allows dramatically lower production
costs for our wholly-owned hemp CBD product lines, thereby
generating more revenue for each product sold. We formulate and
manufacture the majority of our products in our own in-house
formulation centers, also greatly reducing our costs and increasing
revenue. In addition, our extensive domestic and international
media companies ensure we can continuously direct traffic to our
many eCommerce sites and nationwide retail locations.
Freedom Leaf Inc. also sells licenses to use the Freedom Leaf
brand in different countries and states across the globe. We have
entered into three license agreements: for Spain and Portugal, for
The Netherlands, and for Southern California.
Freedom Leaf, Inc. does not handle, grow, sell, or
dispense marijuana or related products.
All of our European activities are in full compliance
with relevant EU laws.
Safe Harbor Statement
Statements in this press release that are not strictly
historical are "forward-looking" statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended. These
forward-looking statements generally can be identified by phrases
such as Freedom Leaf, Inc. or its management "believes," "expects,"
"anticipates," "foresees," "forecasts," "estimates" or other words
or phrases of similar import. Similarly, statements herein that
describe the Company's business strategy, outlook, objectives,
plans, intentions or goals also are forward-looking statements. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Factors that could cause
or contribute to differences include the uncertainty regarding
viability and market acceptance of the Company's products and
services, changes in relationships with third parties, and other
factors described in the Company's most recent periodic filings
with the Securities and Exchange Commission, including its Annual
Report on Form 10-K dated June 30, 2016 and quarterly reports on
Form 10-Q.
Contact: Raymond Medeiros PR and Business Development Director Phone: 415-601-1974 ray@freedomleaf.com